Market Research Logo

Netherlands Pharmaceuticals and Healthcare Report Q4 2017

Netherlands Pharmaceuticals and Healthcare Report Q4 2017

BMI View:

We expect the contraction the Dutch pharmaceutical market has experienced in recent years tocome to an end in 2017, although growth in the coming years will be sluggish. Medicine sales will be drivenmainly by an ageing population and rising prevalence of chronic diseases, which will increase demand forinnovative medicines. However, prevailing public perceptions of drug prices being too high and the risingcost of healthcare will force the government to adhere to its pro-generic stance and cost-containmentpolicies.

Headline Expenditure Projections

Pharmaceuticals: EUR5.97bn (USD6.61bn) in 2016 to EUR6.00bn (USD6.60bn) in 2017; +0.4% inlocal currency terms and -0.1% in US dollar terms.

Healthcare: EUR73.78bn (USD81.62bn) in 2016 to EUR75.04bn (USD82.55bn) in 2017; +1.7% in localcurrency terms and 1.1% in US dollar terms.

Risk/Reward Index

Western Europe is home to some of the most attractive pharmaceutical markets globally. However, despitethere being obvious rewards for companies looking to launch medicines in the region, it is vital thatcompanies appreciate the varying levels of both investment risk and reward that are present in the marketsin Western Europe. BMI's Innovative Pharmaceuticals

Risk/Reward Index

tool, which provides a globallycomparative and numerically based assessment of a market's attractiveness for companies looking to launcha high-value drug, was established to address this.


BMI Industry View
Table: Headline Pharmaceuticals & Healthcare Forecasts (Netherlands 2015-2021)
SWOT
Industry Forecast
Pharmaceutical Market Forecast
Table: Pharmaceutical Sales, Historical Data And Forecasts (Netherlands 2013-2021)
Healthcare Market Forecast
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Netherlands 2013-2021)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Netherlands 2013-2021)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Netherlands 2013-2021)
Prescription Drug Market Forecast
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Netherlands 2013-2021)
Patented Drug Market Forecast
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Netherlands 2013-2021)
Netherlands
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Netherlands 2013-2021)
OTC Medicine Market Forecast
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Netherlands 2013-2021)
Pharmaceutical Trade Forecast
Table: Pharmaceutical Trade Data And Forecasts (Netherlands 2015-2021)
Table: Pharmaceutical Trade Data And Forecasts local currency (Netherlands 2015-2021)
Industry Risk Reward Index
Western Europe Pharmaceuticals: Large Market Sizes Boost Attractiveness
Regulatory Review
Intellectual Property Issues
Pricing Regime
Reimbursement Regime
Market Overview
Healthcare Sector
Table: Healthcare Resources (Netherlands 2011-2016)
Table: Healthcare Personnel (Netherlands 2011-2016)
Table: Healthcare Activity (Netherlands 2011-2016)
Table: Key Points Of The Dutch Health Insurance Act, January 1 2006
Table: Biosimilars Approved In The EU
Research & Development
Clinical Trials
Epidemiology
Competitive Landscape
Research-Based Industry
Generic Drugmakers
Table: Multinational Market Activity
Pharmaceutical Distribution
Pharmaceutical Retail Sector
Company Profile
GlaxoSmithKline
Merck & Co
Novartis
Pfizer
Pharming Group
Qiagen
Sanofi
DSM
Demographic Forecast
Demographic Outlook
Table: Population Headline Indicators (Netherlands 1990-2025)
Table: Key Population Ratios (Netherlands 1990-2025)
Table: Urban/Rural Population & Life Expectancy (Netherlands 1990-2025)
Table: Population By Age Group (Netherlands 1990-2025)
Table: Population By Age Group % (Netherlands 1990-2025)
Glossary
Methodology
Pharmaceutical Expenditure Forecast Model
Healthcare Expenditure Forecast Model
Notes On Methodology
Risk/Reward Index Methodology
Table: Indicators - Rationale And Sources

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report